Mid-esophagus unresectable cancer treated with a low cost stent. First experience

BACKGROUND: In the cancer of the esophagus, with recent technologic advances, self-expanding metal stents (SEMS) are at the forefront of the armamentarium for re-establishing luminal patency. Weighed against the numerous advantages of stents are the import conditions and the cost. In light of this,...

Descripción completa

Detalles Bibliográficos
Autores principales: Felix, Valter N, Caetano, Alaor, Cipullo, Jose P, Almodova, Emiliano C, Colaiacovo, Wagner, Zamboti, Aldenir F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226661/
https://www.ncbi.nlm.nih.gov/pubmed/22075135
http://dx.doi.org/10.1186/1756-0500-4-486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226661/
https://www.ncbi.nlm.nih.gov/pubmed/22075135
http://dx.doi.org/10.1186/1756-0500-4-486

Ejemplares similares